| scholarly article | Q13442814 |
| P50 | author | Marco Duering | Q57008377 |
| Hugues Chabriat | Q57687005 | ||
| Carole Dufouil | Q58275775 | ||
| Andreas Gschwendtner | Q71921278 | ||
| Ophelia Godin | Q88913882 | ||
| Jean-Pierre Guichard | Q90468558 | ||
| Nils Peters | Q90783050 | ||
| Chahin Pachai | Q114425015 | ||
| Marie-Germaine Bousser | Q15649495 | ||
| Martin Dichgans | Q30422338 | ||
| Eric Jouvent | Q43135103 | ||
| Markus Holtmannspötter | Q47460836 | ||
| P2093 | author name string | Michael O'Sullivan | |
| Anand Viswanathan | |||
| P433 | issue | 9 | |
| P921 | main subject | magnetic resonance imaging | Q161238 |
| vascular dementia | Q583908 | ||
| dementia | Q83030 | ||
| P304 | page(s) | 1629-1636 | |
| P577 | publication date | 2008-10-15 | |
| P1433 | published in | Neurobiology of Aging | Q7002141 |
| P1476 | title | Impact of MRI markers in subcortical vascular dementia: a multi-modal analysis in CADASIL. | |
| P478 | volume | 31 |
| Q48574046 | A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion Histograms |
| Q49455279 | A panel of clinical and neuropathological features of cerebrovascular disease through the novel neuroimaging methods. |
| Q36276474 | Aging, the Central Nervous System, and Mobility in Older Adults: Neural Mechanisms of Mobility Impairment |
| Q37988907 | Cell-to-cell communication and vascular dementia |
| Q36288849 | Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects |
| Q38109534 | Cerebral microbleeds: a guide to detection and clinical relevance in different disease settings |
| Q33401999 | Cerebral microbleeds: a guide to detection and interpretation |
| Q45734278 | Change in multimodal MRI markers predicts dementia risk in cerebral small vessel disease. |
| Q95840655 | Clinical and Genetic Aspects of CADASIL |
| Q50200928 | Clinical correlates of longitudinal MRI changes in CADASIL. |
| Q92671707 | Clinical practice guideline for cognitive impairment of cerebral small vessel disease |
| Q30797186 | Current pathophysiological concepts in cerebral small vessel disease |
| Q44055279 | Decreased T1 contrast between gray matter and normal-appearing white matter in CADASIL. |
| Q33547027 | Demyelinating disorders |
| Q90454460 | Different Types of White Matter Hyperintensities in CADASIL |
| Q31157280 | Different types of white matter hyperintensities in CADASIL: Insights from 7-Tesla MRI. |
| Q30487788 | Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain |
| Q36300061 | Effects of amyloid and vascular markers on cognitive decline in subcortical vascular dementia |
| Q35675985 | Effects of lacunar infarctions on cognitive impairment in patients with cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy. |
| Q52148715 | First magenetic resonance imaging studies on aluminium maltolate-treated aged New Zealand rabbits: an Alzheimer's animal model. |
| Q34522989 | Genetic stroke syndromes |
| Q94483951 | Genome-wide association study of MRI markers of cerebral small vessel disease in 42,310 participants |
| Q35851278 | Grey matter volume alterations in CADASIL: a voxel-based morphometry study |
| Q34105431 | In vivo high-resolution 7 Tesla MRI shows early and diffuse cortical alterations in CADASIL. |
| Q47988548 | Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease |
| Q30945201 | Ischemic brain injury in cerebral amyloid angiopathy |
| Q59127919 | MRI Lesion Load of Cerebral Small Vessel Disease and Cognitive Impairment in Patients With CADASIL |
| Q33785359 | Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker |
| Q34683943 | Mechanisms of cognitive impairment in cerebral small vessel disease: multimodal MRI results from the St George's cognition and neuroimaging in stroke (SCANS) study. |
| Q47850113 | Microstructure of Strategic White Matter Tracts and Cognition in Memory Clinic Patients with Vascular Brain Injury |
| Q35870173 | Multiparametric magnetic resonance imaging of brain disorders. |
| Q93160279 | Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL |
| Q39331001 | Prediction of 3-year clinical course in CADASIL. |
| Q47621582 | Reaction Time Is Negatively Associated with Corpus Callosum Area in the Early Stages of CADASIL. |
| Q35870878 | Recent progress on small vessel disease with cognitive impairment |
| Q30250336 | Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease |
| Q64118319 | Serum Neurofilament light correlates with CADASIL disease severity and survival |
| Q36999165 | Small vessel disease and cognitive impairment: The relevance of central network connections. |
| Q45891304 | Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in CADASIL. |
| Q57476259 | The role of clinical and neuroimaging features in the diagnosis of CADASIL |
| Q33967781 | Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association |
Search more.